Statistics about Health, Pharma & Medtech in United States
Statistics
- Drug products in the pipeline in California 2020, by therapeutic area
- U.S. bioscience employment by subsector 2023
- Annual average cost of orphan drugs per patient 2014-2018
- Prescription antidepressant drug use in the U.S. by gender 1988-2014
- Number of orphan designations accepted in the U.S. 2003-2023
- Rx medicine out-of-pocket expense per person by insurance status 1987-2014
- Rx medicine out-of-pocket expense per person by age in the U.S. 1987-2014
- Rx medicine out-of-pocket expense per person in the U.S. 1987-2014
- Health care and medicine expense by insurance status in the U.S. 1987-2014
- Health care and medicine expense per person by gender 1987-2014
- Health care and medicine expense per person in the U.S. 1987-2014
- Health care and medicine expense per person 1987-2014
- Time from brand drug launch to generic patent challenges U.S. 1995-2014
- Washington D.C.'s medical cannabis spending 2018-2024
- U.S. marijuana and common stimulants-substances retail market size 2016
- CHina's share in U.S imports of antibiotic products 2019
- U.S. adults and their impression of being prescribed not needed drug 2017
- Percentage change in opioid prescriptions in the U.S. from 2012 to 2021, by state
- Price disparities for top product Januvia U.S. vs international 2024
- Number of buprenorphine prescriptions dispensed from U.S. pharmacies, 2017-2023
- Price disparities for Spiriva Handihaler - U.S. and international 2024
- Percentage increase in U.S. pharmacy naloxone prescriptions 2018-2023
- Price disparities for top product Symbicort - U.S. and international 2024
- Price disparities for top product Viagra - U.S. and international 2024
- Price disparities for top product Xarelto - U.S. and international 2024
- Prescriptions for opioid use disorder dispensed in U.S. pharmacies 2012-2021
- Percentage increase in U.S. pharmacy prescriptions for opioid use disorder 2012-2021
- Number of furosemide prescriptions in the U.S. 2004-2022
- U.S import value of Chinese antibiotic products 2019
- Drug overdose male death rates in the U.S. 2018, by age
- Share of U.S. 12th graders who used OxyContin in the past year 2002-2023
- Past year nonmedical use of pain relievers by race/ethnicity in the U.S. 2017-2022
- U.S. projected prescription drug spending by payer share 2018-2026
- Cencora's earnings per share 2019-2024
- Cencora's operating income pharmaceutical products 2021-2024
- Number of employees at Cencora 2019-2024
- Cencora's operating expenses, by type 2022-2024
- Cencora's revenue, by operation 2022-2024
- Prescription drug expenditure by age group
- Alaska's medical cannabis spending 2018-2024
- U.S. adults who tried osteopathy by annual income 2017
- Estimated clinical trial cost per patient by therapeutic class 2015-2017
- U.S. total vs. generic dispensed prescription numbers 2017, by formulation
- U.S. adults who heard of opioids by ethnicity 2017
- U.S. adults who heard of opioids by age group 2017
- U.S. adults who who feared addiction to opioids 2017
- U.S. adults opinion on responsibility for high consumption of opioids 2017
- Cumulative price change of orphan drugs in the U.S. 2012-2014
- Comparison of pre-expiry and generic price for drugs U.S. 2015
- Intranasal antihistamines market size worldwide 2014-2024
- U.S. top 20 branded drugs based on retail sales 2011
- U.S. top 20 branded drugs based on units sold 2011
- Spending on dispensed total vs. generic prescriptions in the U.S. 2017
- U.S. adults who feared addiction to opioids by age group 2017
- Reasons for missing a dose of prescribed medication in the U.S. 2017, by generation
- Reasons for missing a dose of prescribed medication in the U.S. 2017, by age
- Total statutory rebates and fees for brand medicines in US by component 2013-2020
- Total point of sale payments for brand medicines in the U.S. 2013-2020
- Market access rebates and discounts for brand medicines by component U.S. 2013-2020
- Per patient cost of medication non-adherence by select disease per year 2017
- Major concerns among adults regarding personalized medicine in the U.S. in 2018
- U.S. opinions on insurance coverage of personalized tests and treatments in 2018
- Reactions among U.S. adults to description of personalized medicine 2018
- U.S. adults opinion on responsibility for high consumption of opioids by age 2017
- Opinion of US adults on "opioid epidemic" as an expression by age group 2017
- Reasons for consumption of opioids by U.S. adults 2017
- U.S. adults who tried homeopathy 2017
- U.S. adults who tried alternative medical treatments 2017
- U.S. adults who tried osteopathy by age group 2017
- U.S. adults who were prescribed unnecessary amount of opioids 2017, by gender
- U.S. adults share with positive view on alternative medicine by community 2017
- U.S. adults with positive views on alternative medicine by income 2017
- U.S. adults with positive views on alternative medicine by ethnicity 2017
- U.S. adults with positive views on alternative medicine by age 2017
- U.S. adults with positive view on complementary and alternative medicine 2017
- Effectiveness of alternative medicine to conventional medicine by condition US 2017
- U.S. adults who heard of opioids 2017
- Actual need of opioids for everyone who is prescribed by age group US 2017
- U.S. adults who tried homeopathy by age group 2017
- U.S. adults who tried homeopathy by annual income 2017
- U.S. adults who took opioids in last 2 years 2017
- U.S. adults who tried homeopathy by community type 2017
- Share of U.S. opioid consumers who consumed prescribed opioids 2017
- U.S. adults who were prescribed unnecessary amount of opioids 2017
- Actual need of opioids for everyone who is prescribed US 2017
- U.S. adults who took opioids in the last 2 years by age group 2017
- U.S. adults who took prescribed opioids by age group 2017
- Opinion of US adults on opioid epidemic as an expression 2017
- Estimated clinical trial cost per drug by therapeutic class 2015-2017
- Value of pharmaceutical gross-to-net reduction in the U.S. 2019-2023
- Key measurements of U.S. CDER drug approvals in 2023
- Number of losartan prescriptions in the U.S. 2004-2022
- Percentage of U.S. drug shortages by administration route 2001-2024
- New drug shortages in the U.S. 2001-2024
- Top therapy areas in the U.S. by number of prescriptions 2022
- Share of U.S. opioid ED visits prescribed naloxone or buprenorphine 2019-2021
- Participation in clinical trials recommended by a doctor among U.S. adults 2021
- Annual percentage change of DTCA expenditure for Namenda XR in the U.S. 2013-2018
- Annual percentage change of DTCA expenditure for Eliquis U.S. 2013-2018
- U.S. top 20 branded drugs based on prescriptions 2014-2015